abstract |
The present invention relates to a TNIK inhibitor, a pharmaceutical composition, and a method for treating a cancer patient with a TNIK inhibitor. The present invention also relates to a novel aminothiazole derivative. The TNIK inhibitor is represented by the following formula (I), and R1, R2, R3, R4, R5 and R6 each independently represents a hydrogen atom or a substituent. [Chemical 1] |